-
Symbol
-
APUS on NYSE
-
Investment type
-
Equity / Common stock, par value $0.01 per share
-
Latest Disclosed Shares Owned
-
4,316,618 shares
-
Security Ownership %
-
34%
Apimeds Inc. ownership in Apimeds Pharmaceuticals US, Inc. Common stock, par value $0.01 per share (APUS)
26 Jan 2026 - Apimeds Inc. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,316,618 shares of Apimeds Pharmaceuticals US, Inc. Common stock, par value $0.01 per share (APUS).
This represents 34% ownership of the company.
In their previous filing dated 19 May 2025, Inscobee Inc. had reported owning 4,387,708 shares, indicating a decrease of +1.6%.
.